Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.
Clicks: 101
ID: 115968
1996
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
101 views
15 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #267 of 292 articles by views in Proceedings of the National Academy of Sciences of the United States of America
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 292 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The synthetic peptides DP-107 and DP-178 (T-20), derived from separate domains within the human immunodeficiency virus type 1 (HIV-1) transmembrane (TM) protein, gp4l, are stable and potent inhibitors of HIV-1 infection and fusion. Using a computer searching ...
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (37 words).
Try re-searching for a better abstract.
| Reference Key |
jr1996proceedingspeptides
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | D M Lambert, S Barney, A L Lambert, K Guthrie, R Medinas, D E Davis, T Bucy, J Erickson, G Merutka, S R Petteway, Jr;D M Lambert;S Barney;A L Lambert;K Guthrie;R Medinas;D E Davis;T Bucy;J Erickson;G Merutka;S R Petteway, Jr; |
| Journal | Proceedings of the National Academy of Sciences of the United States of America |
| Year | 1996 |
| DOI |
10.1073/pnas.93.5.2186
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.